USPTO serial 79069504
RARE DISEASE DAY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 21, 2010
- Examiner
- SPARACINO, MARK V
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with RARE DISEASE DAY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
FR
Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
FR
Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
Paris, FR
Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Charitable fund raising, in particular, fund raising to promote and support scientific and clinical research, development of treatments, dissemination and harnessing of knowledge, raising of public awareness and improvement of the quality of patients' lives, in the field of rare diseases | ACTIVE | — |
| 041 | [ Education in the field of rare diseases, namely, providing classes in the field of rare diseases; ] training in the field of rare diseases, namely, providing seminars in the field of rare diseases; [ ongoing shows featuring comedy, news, music concerts, beauty contests, drama performances, ballet performances and fashion shows broadcast over television, radio and the internet, all for the purpose of find raising to promote and support scientific and clinical research, development of treatments, dissemination and harnessing of knowledge, raising of public awareness and improvement of the quality of patients' lives, in the field of rare diseases; ] sporting and cultural activities for the purpose of fund raising to promote and support scientific and clinical research, development of treatments, dissemination and harnessing of knowledge, raising of public awareness and improvement of the quality of patients' lives, in the field of rare diseases, namely, organization of colloquiums, conferences, and seminars in the field of rare diseases; [ organization of charity dance contests, and sport competitions, namely, crew, badminton, basket ball, boxing, canoeing, cycling, horse riding, fencing, soccer, gymnastics, weightlifting, handball, hockey, judo, wrestling, swimming, pentathlon, taekwondo, tennis, table tennis, rowing, shooting, archery, triathlon, sailing, volley ball, biathlon, bob-sledding, curling, ice hockey, luge, ice skating, skiing, tug-of-war, rugby, polo, and golf all for the purpose of fund raising to promote and support scientific and clinical research, development of treatments, dissemination and harnessing of knowledge, raising of public awareness and improvement of the quality of patients' lives, in the field of rare diseases; ] arranging and conducting conferences, colloquiums, seminars and symposiums to raise public awareness, in particular that of national and international institutions, in the field of rare diseases; [ publication of books concerning rare diseases; ] publication of texts concerning rare diseases [ ongoing radio and television programs for the purpose of fund raising to promote and support scientific and clinical research, development of treatments, dissemination and harnessing of knowledge, raising of public awareness and improvement of the quality of patients' lives, in the field of rare diseases; production of radio and television programs concerning rare diseases; education, training and instruction in the field of rare diseases, namely, providing workshops in the field of rare diseases ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
- Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
- Other trademarks owned by EUROPEAN ORGANISATION FOR RARE DISEASES EURORDIS
- Other trademarks in Class 036
- Other trademarks in Class 041
- Similar marks named RARE DISEASE DAY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 4, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 4, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2022 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 13, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Nov 13, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 17, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 17, 2021 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 17, 2021 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 4, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 21, 2019 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 13, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 11, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 21, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 9, 2017 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 9, 2017 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 6, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 21, 2016 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 31, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 8, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 13, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 13, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 21, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 21, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 6, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 6, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 2, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 28, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 10, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 10, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2010 | PAPER RECEIVED | — | |
| Jan 22, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 21, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 29, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2009 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2009 | PAPER RECEIVED | — | |
| Aug 28, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 16, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 15, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Jul 9, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |